Nabriva Therapeutics Plc

NASDAQ:NBRV   3:15:22 PM EDT
1.09
-0.04 (-3.11%)
Earnings Announcements

Nabriva Therapeutics Posts Qtrly Loss Per Share $1.11

Published: 03/11/2021 23:10 GMT
Nabriva Therapeutics Plc (NBRV) - Quarterly Revenue $2.5 Million Versus $300,000.
Qtrly Loss per Share $1.11.
Revenue is expected to be $7.46 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $9.94 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.